Logo image of ASGN

ASGN INC (ASGN) Stock Fundamental Analysis

USA - NYSE:ASGN - US00191U1025 - Common Stock

51.24 USD
-0.26 (-0.5%)
Last: 9/15/2025, 8:04:00 PM
51.24 USD
0 (0%)
After Hours: 9/15/2025, 8:04:00 PM
Fundamental Rating

5

Overall ASGN gets a fundamental rating of 5 out of 10. We evaluated ASGN against 86 industry peers in the IT Services industry. ASGN has an average financial health and profitability rating. ASGN has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ASGN was profitable.
ASGN had a positive operating cash flow in the past year.
Each year in the past 5 years ASGN has been profitable.
In the past 5 years ASGN always reported a positive cash flow from operatings.
ASGN Yearly Net Income VS EBIT VS OCF VS FCFASGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

With a decent Return On Assets value of 3.77%, ASGN is doing good in the industry, outperforming 62.79% of the companies in the same industry.
ASGN has a Return On Equity of 7.67%. This is in the better half of the industry: ASGN outperforms 62.79% of its industry peers.
ASGN has a better Return On Invested Capital (5.97%) than 61.63% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ASGN is significantly below the industry average of 21.79%.
Industry RankSector Rank
ROA 3.77%
ROE 7.67%
ROIC 5.97%
ROA(3y)6.26%
ROA(5y)7.32%
ROE(3y)11.85%
ROE(5y)14.03%
ROIC(3y)8.44%
ROIC(5y)8.19%
ASGN Yearly ROA, ROE, ROICASGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a Profit Margin value of 3.50%, ASGN perfoms like the industry average, outperforming 58.14% of the companies in the same industry.
ASGN's Profit Margin has declined in the last couple of years.
ASGN has a Operating Margin (6.67%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ASGN has declined.
ASGN has a Gross Margin of 28.84%. This is in the lower half of the industry: ASGN underperforms 63.95% of its industry peers.
In the last couple of years the Gross Margin of ASGN has remained more or less at the same level.
Industry RankSector Rank
OM 6.67%
PM (TTM) 3.5%
GM 28.84%
OM growth 3Y-5.33%
OM growth 5Y-1.69%
PM growth 3Y-25.23%
PM growth 5Y-3.53%
GM growth 3Y0.44%
GM growth 5Y0.3%
ASGN Yearly Profit, Operating, Gross MarginsASGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

ASGN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ASGN has less shares outstanding
The number of shares outstanding for ASGN has been reduced compared to 5 years ago.
ASGN has a worse debt/assets ratio than last year.
ASGN Yearly Shares OutstandingASGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ASGN Yearly Total Debt VS Total AssetsASGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

ASGN has an Altman-Z score of 2.60. This is not the best score and indicates that ASGN is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.60, ASGN is in line with its industry, outperforming 47.67% of the companies in the same industry.
ASGN has a debt to FCF ratio of 3.57. This is a good value and a sign of high solvency as ASGN would need 3.57 years to pay back of all of its debts.
ASGN has a Debt to FCF ratio of 3.57. This is in the better half of the industry: ASGN outperforms 62.79% of its industry peers.
ASGN has a Debt/Equity ratio of 0.66. This is a neutral value indicating ASGN is somewhat dependend on debt financing.
ASGN has a Debt to Equity ratio of 0.66. This is comparable to the rest of the industry: ASGN outperforms 40.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 3.57
Altman-Z 2.6
ROIC/WACC0.68
WACC8.82%
ASGN Yearly LT Debt VS Equity VS FCFASGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 2.11 indicates that ASGN has no problem at all paying its short term obligations.
ASGN's Current ratio of 2.11 is fine compared to the rest of the industry. ASGN outperforms 60.47% of its industry peers.
A Quick Ratio of 2.11 indicates that ASGN has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.11, ASGN is doing good in the industry, outperforming 61.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 2.11
ASGN Yearly Current Assets VS Current LiabilitesASGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for ASGN have decreased strongly by -15.04% in the last year.
Measured over the past 5 years, ASGN shows a small growth in Earnings Per Share. The EPS has been growing by 2.16% on average per year.
Looking at the last year, ASGN shows a decrease in Revenue. The Revenue has decreased by -6.31% in the last year.
ASGN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.72% yearly.
EPS 1Y (TTM)-15.04%
EPS 3Y-2.25%
EPS 5Y2.16%
EPS Q2Q%-13.97%
Revenue 1Y (TTM)-6.31%
Revenue growth 3Y0.74%
Revenue growth 5Y3.72%
Sales Q2Q%-1.36%

3.2 Future

ASGN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.24% yearly.
The Revenue is expected to grow by 1.63% on average over the next years.
EPS Next Y-12.54%
EPS Next 2Y-1.08%
EPS Next 3Y4.24%
EPS Next 5YN/A
Revenue Next Year-3.48%
Revenue Next 2Y-0.57%
Revenue Next 3Y1.63%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ASGN Yearly Revenue VS EstimatesASGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
ASGN Yearly EPS VS EstimatesASGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.68, the valuation of ASGN can be described as reasonable.
ASGN's Price/Earnings ratio is rather cheap when compared to the industry. ASGN is cheaper than 90.70% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.27, ASGN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.01, the valuation of ASGN can be described as reasonable.
90.70% of the companies in the same industry are more expensive than ASGN, based on the Price/Forward Earnings ratio.
ASGN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.77, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.68
Fwd PE 10.01
ASGN Price Earnings VS Forward Price EarningsASGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

ASGN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ASGN is cheaper than 83.72% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ASGN is valued cheaper than 95.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.62
EV/EBITDA 9
ASGN Per share dataASGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)4.94
EPS Next 2Y-1.08%
EPS Next 3Y4.24%

0

5. Dividend

5.1 Amount

ASGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ASGN INC

NYSE:ASGN (9/15/2025, 8:04:00 PM)

After market: 51.24 0 (0%)

51.24

-0.26 (-0.5%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-21 2025-10-21/amc
Inst Owners100.52%
Inst Owner Change-2.53%
Ins Owners3.59%
Ins Owner Change-0.02%
Market Cap2.24B
Analysts72.31
Price Target58.65 (14.46%)
Short Float %4.54%
Short Ratio3.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.37%
Min EPS beat(2)-5.06%
Max EPS beat(2)5.79%
EPS beat(4)3
Avg EPS beat(4)1.87%
Min EPS beat(4)-5.06%
Max EPS beat(4)5.79%
EPS beat(8)7
Avg EPS beat(8)2.52%
EPS beat(12)8
Avg EPS beat(12)1.43%
EPS beat(16)12
Avg EPS beat(16)3.13%
Revenue beat(2)1
Avg Revenue beat(2)-0.38%
Min Revenue beat(2)-1.31%
Max Revenue beat(2)0.55%
Revenue beat(4)1
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-3.43%
Max Revenue beat(4)0.55%
Revenue beat(8)1
Avg Revenue beat(8)-1.6%
Revenue beat(12)1
Avg Revenue beat(12)-1.77%
Revenue beat(16)3
Avg Revenue beat(16)-1.28%
PT rev (1m)0%
PT rev (3m)-6.25%
EPS NQ rev (1m)0.59%
EPS NQ rev (3m)-0.16%
EPS NY rev (1m)1.52%
EPS NY rev (3m)0.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.65%
Valuation
Industry RankSector Rank
PE 10.68
Fwd PE 10.01
P/S 0.56
P/FCF 6.62
P/OCF 5.94
P/B 1.23
P/tB N/A
EV/EBITDA 9
EPS(TTM)4.8
EY9.37%
EPS(NY)5.12
Fwd EY9.99%
FCF(TTM)7.74
FCFY15.11%
OCF(TTM)8.62
OCFY16.83%
SpS91.44
BVpS41.71
TBVpS-18.3
PEG (NY)N/A
PEG (5Y)4.94
Profitability
Industry RankSector Rank
ROA 3.77%
ROE 7.67%
ROCE 8.14%
ROIC 5.97%
ROICexc 6.23%
ROICexgc 38.16%
OM 6.67%
PM (TTM) 3.5%
GM 28.84%
FCFM 8.47%
ROA(3y)6.26%
ROA(5y)7.32%
ROE(3y)11.85%
ROE(5y)14.03%
ROIC(3y)8.44%
ROIC(5y)8.19%
ROICexc(3y)8.85%
ROICexc(5y)8.94%
ROICexgc(3y)45.83%
ROICexgc(5y)47.14%
ROCE(3y)11.51%
ROCE(5y)11.17%
ROICexcg growth 3Y-8.35%
ROICexcg growth 5Y2.66%
ROICexc growth 3Y-8.5%
ROICexc growth 5Y-0.68%
OM growth 3Y-5.33%
OM growth 5Y-1.69%
PM growth 3Y-25.23%
PM growth 5Y-3.53%
GM growth 3Y0.44%
GM growth 5Y0.3%
F-Score5
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 3.57
Debt/EBITDA 3.29
Cap/Depr 37.89%
Cap/Sales 0.96%
Interest Coverage 4.15
Cash Conversion 102.47%
Profit Quality 242.11%
Current Ratio 2.11
Quick Ratio 2.11
Altman-Z 2.6
F-Score5
WACC8.82%
ROIC/WACC0.68
Cap/Depr(3y)39.16%
Cap/Depr(5y)38.51%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.87%
Profit Quality(3y)166.38%
Profit Quality(5y)146.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.04%
EPS 3Y-2.25%
EPS 5Y2.16%
EPS Q2Q%-13.97%
EPS Next Y-12.54%
EPS Next 2Y-1.08%
EPS Next 3Y4.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.31%
Revenue growth 3Y0.74%
Revenue growth 5Y3.72%
Sales Q2Q%-1.36%
Revenue Next Year-3.48%
Revenue Next 2Y-0.57%
Revenue Next 3Y1.63%
Revenue Next 5YN/A
EBIT growth 1Y-19.89%
EBIT growth 3Y-4.63%
EBIT growth 5Y1.96%
EBIT Next Year37.71%
EBIT Next 3Y16.33%
EBIT Next 5YN/A
FCF growth 1Y7.89%
FCF growth 3Y31.88%
FCF growth 5Y5.39%
OCF growth 1Y5.98%
OCF growth 3Y27.34%
OCF growth 5Y5.01%